Literature DB >> 23645957

The Antibacterial Activity of Selected Labiatae (Lamiaceae) Essential Oils against Brucella melitensis.

Ayman Al-Mariri1, Mazen Safi.   

Abstract

BACKGROUND: Brucellosis, a zoonosis caused by four species of brucella, has a high morbidity. The major cause of brucellosis worldwide is brucella melitensis. Medicinal plants are considered as new antibacterial sources that could replace conventional antibiotics in the treatment of antibiotic-resistant bacteria. The aim of this study was to evaluate the efficacy of some native plants, alone and in combination with some antibiotics, in the treatment of brucellosis.
METHODS: The present experimental in vitro study was carried out to evaluate the anti-brucella activities of essential oils of Rosmarinus officinalis L., Origanum syriacum, Thymus syriacus, Salvia palaestina Benth, Mentha piperia, and Lavandula stoechas L., alone and in combination with some antibiotics. The activity against 16 tetracycline-resistant B. melitensis isolates was determined by disc diffusion method incorporating a concentration of 5%. Antibiotic discs were also used as a control. Microdilution brucella broth susceptibility assay was used in order to determine the MICs of essential oils and five antibiotics.
RESULTS: Among all the herbs evaluated, only the essential oils of O. syriacum and T. syriacus plants demonstrated most effective anti-brucella activity, and were then chosen for MIC study. The minimal inhibitory concentrations (MIC50) of essential oils of O. syriacum and T. syriacus against tetracycline-resistant B. melitensis were 3.125 µl/ml and 6.25 µl/ml, respectively.
CONCLUSION: Among the essential oils studied, those of O. syriacum and T. syriacus were most effective. Since a combination of levofloxacin and Thymus syriacus essential oil increased the efficacy of this antibiotic, O. syriacum and T. syriacus are recommended to be used as bactericidal agents against B. melitensis.

Entities:  

Keywords:  Antibiotic resistance; Brucella melitensis; Brucellosis; Origanum

Year:  2013        PMID: 23645957      PMCID: PMC3642944     

Source DB:  PubMed          Journal:  Iran J Med Sci        ISSN: 0253-0716


Introduction

Brucellosis is an endemic zoonosis in Syria, affecting large numbers of animals and an increasing number of cases in humans. It is considered as the most important public health problem due to its high morbidity. The severity of disease in humans correlates with its severity in animals, especially in domestic ruminants.[1] Furthermore, brucellosis continues to have great economic importance considering decreased milk production, infertility, abortions, and weight loss.[2] Brucella melitensis remains the major cause of human disease worldwide, followed by B. abortus and B. suis. Rare cases of human infections caused by B. canis and pathogenic brucella of marine mammals have also been reported.[3],[4] Despite existing brucellosis worldwide, it is considered as an endemic disease in Mediterranean basin, Middle East, Western Asia, Africa, and Latin America.[5] In spite of the development of new antibiotics as well as new treatment strategies, only few modifications have been applied to brucellosis treatment since its introduction half a century ago.[6]-[8] Treatment of human brucellosis is still based on the World Health Organization (WHO) recommendations applied in 1986,[9] suggesting the use of doxycycline, 100 mg twice daily for six weeks combined with either rifampicin, 600–900 mg daily for six weeks, or streptomycin, 1 g daily for 2–3 weeks. In addition, rifampicin monotherapy is the only viable option for treatment during pregnancy. Whereas a combined therapy with rifampicin and trimethoprim-sulfomethoxazole is recommended for children.[10],[11] Some disease complications, such as: endocarditis, meningitis, and spondylitis, were treated with triple-antibiotic combinations.[12],[13] Quinolones are an alternative to conventional treatment agents,[14]-[16] and clinically similar results were obtained with rifampicin-ofloxacin and rifampicin-doxycycline combinations.[17] However, the treatment of brucellosis is still problematic due to emerging resistance, which yield to high rates of treatment failure and relapses. Thus, it is necessary to develop new antibacterial drugs for treatment of brucellosis.[18] The antimicrobial activity of medicinal plant extracts justifies them to be used in many fields such as food industry, pharmacy and medicine. Medicinal plants have always been sources for discovery of new drugs. Plants, easily protect themselves against various enemies such as insects and microorganisms by synthesizing special substances.[19] Moreover, they maintain their normal growth and development by producing secondary antimicrobial metabolites.[20] Brillantaisia lamium extract is found to be of value against Staphylococcus aureus, Enterococcus faecalis, Candida tropicalis and Cryptococcus neoformans.[21] Whereas, Crimum pupurascens herb extracts and its components showed antimicrobial activity against Salmonella paratyphi A and B.[22] In addition, a strong anti brucella abortus A77 activity of Satureja hortensis essential oil has already been reported.[23] Lamiaceae family main components, thymol and carvacrol, interfere with cellular metabolism after penetrating into the cell.[24] Low concentrations of Prunus mahaleb seeds ethanolic extract showed a good efficacy against B. melitensis.[25] Furthermore, the lowest concentration of ethanolic and methanolic extracts of Oliveria decumbens and Vitex pseudo-negundo found to have antibacterial activity against tetracycline-resistant B. melitensis.[26],[27] In addition, almost all concentrations of Teucrium polium ethanolic extract, a member of the Lamiaceae family, were found to be effective against B. melitensis.[27] Rosmarinus officinalis L., Origanum syriacum, Thymus syriacus, Salvia palaestina Benth, Mentha piperia and Lavandula stoechas L. are traditional medicinal plants used in Syria for many purposes, particularly for respiratory and gastrointestinal disorders. The aim of this study was to evaluate in vitro antibacterial activity of essential oils of the above-mentioned plants against tetracycline-resistant B. melitensis isolates.

Materials and Methods

Microorganisms and Growth Conditions In this prospective study, 89 brucella species were isolated from bovine and ovine milk from different Syrian provinces between 2004 and 2007. Bacteria were isolated from milk cultures at the Immunology and Microbiology Laboratory, atomic energy commission of syria (AECS).[28] Brucella was grown under optimal conditions in 2YT agar (Difco, BD, USA), containing peptone 10 g, sodium chloride 5 g, meat extract 5 g, agar 20 g, and distilled water 1 liter, and incubated at 37°C water bath (Grant water; Cambridge, UK.) to secure sufficient cell density. The growth of contaminating microorganisms was inhibited by supplementing the growth medium with cycloheximide 100 mg, bacitracin 25000 units, polymyxin B sulphate 5000 units, vancomycin 20 mg, nalidixic acid 5 mg, and nystatin 100000 units (Oxoid, UK).[28] The solid selective media were then prepared by melting the basal medium, cooling to 56°C in a water bath, adding appropriate amounts of stock solutions of the antibiotics and 5% horse serum (PAN-Biotech, Gmbh, Germany). The biotyping of the bacteria was done by CO2 requirement, H2S production, urease and oxidase positivity, growth in the presence of dyes (thionine and basic fuchsine), and reaction with monospecific anti-A and anti-M sera (Arcomex, Jordan).[29] Strains identified as B. melitensis or B. abortus were stored in 2YT medium at -20°C. Only 16 isolates of B. melitensis resistant to tetracycline by susceptibility test were used in the present study. Plant samples Collection The arial parts of plant samples including the leaves and buds of Rosmarinus officinalis L., Origanum syriacum, Thymus syriacus, Salvia palaestina Benth, Mentha piperia and Lavandula stoechas L. (Labiatae), were collected during the flowering season from their natural habitat in Syria (table 1). The samples were cleaned from impurities, such as contaminating plants, dust, and other pollutants. The collected plants were air dried and were cut to pieces.
Table 1

Plants and their families, collection sites, and parts used

No Scientific name Plant family Collection site Altitude Collection time Extracted part
1 Rosmarinus officinalis .L. Lamiaceae Latakia300 mJuneAerial parts
2 Origanum syriacum.L. Lamiaceae Kafr Nobol-Idlib446 mJulyAerial parts
3 Thymus syriacus. Boiss. Lamiaceae Alsoja mountain-Damascus840 mJulyAerial parts
4 Salvia palaestina Benth Lamiaceae Alyarmouk valley-Konaitera800 mJuneAerial parts
5 Mentha piperia. L. Lamiaceae Latakia300 mJuneAerial parts
6 Lavandula stoechas L. Lamiaceae Tartous300 mJuneAerial parts
Plants and their families, collection sites, and parts used Essential Oil Extraction Extraction of essential oils was carried out using water steam distillation device (Clevenger-type apparatus) according to the European Pharmacopoeia method.[30] The device was attached to condenser and cold water recycler (Hydrodistillation technique). Distilled water was added (1:10 v/v) to each sample, and distilled for 2 h. The supernatant contained essential oil which was dehydrated by filtering through anhydrous Na2SO4. The essential oil thus prepared was collected in airtight vials and stored in refrigerator. Antibacterial Susceptibility Assay The test isolates was grown in Muller-Hinton Broth (MHB, Merck) medium at 37°C for 22 h. The bacterial number in the final inoculum was adjusted to 106 CFU/ml. A bacterial lawn was prepared by pouring 0.1 ml of bacterial suspension onto each plate of Muller-Hinton Agar medium (MHA, Merck), spread by a sterile cotton swab, and allowed to remain in contact for 1 min. 5% concentration of each essential oil were prepared in order to impregnate the paper discs. The sterile filter paper discs containing tested essential oils (6-mm diameter) were then placed on the bacterial lawn. The Petri dishes were subsequently incubated at 37°C for 24 h and the inhibition zone around each disc was measured in mm. As positive controls, discs (Difco, BD, USA) containing tetracycline 30 µg, ciprofloxacin 5 µg, levofloxacin 5 µg, ofloxacin 5 µg and doxycycline 30 µg were used. Antibiotics MIC Determination Microdilution broth method in 96 microwell plates (TPP, Switzerland) was used to estimate the antibiotic’s susceptibility. Two-fold dilutions of antibiotics in brucella broth (acumedia, Michigan, USA) prepared in wells were inoculated with 106 CFU of bacteria with final volume of 0.2 ml in each micro-well plate, and incubated for 48 hours at 37°C. The MIC was expressed as the lowest concentration that completely inhibited visual growth. Furthermore, the lowest concentration inhibiting 90% of visual growth was considered as MIC90. MIC testing was performed according to the recommendations of the clinical laboratory standards institute.[31] The concentrations assayed for each antibiotic ranged from 0.064 to 128 μg/ml. The absorbance was determined at 590 nm (Thermo-lab Systems Reader, Finland). All tests were performed in triplicate and then averaged. The antibiotics investigated included levofloxacin, ofloxacin, sparfloxacin, ciprofloxacin and doxycycline, along with a blank test containing no antibiotics. Determination of MIC of Essential Oils Microdilution broth susceptibility assay was performed using three replicates of each serial dilutions of essential oil prepared in brucella® broth medium in 96-well microtiter plates.[32] The concentrations of each essential oil in serial dilutions ranged from 0.75 to 100 µl/ml. The content of each well was supplemented with 100 μl of freshly grown bacterial culture containing 106 CFU/ml in brucella broth. The assay included positive control without essential oil and negative control lacking bacteria under the same conditions. The plate was incubated with shaking for 24 h at 37°C. The MIC was expressed as the lowest concentration that completely inhibited visual growth. Moreover, MIC90 was the lowest concentration that inhibited 90% of visual growth with absorbance at 590 nm. Essential Oil-Antibiotic Combination Effect Two B. melitensis isolates were employed to evaluate the additive effects of various concentrations of T. syriacus essential oil on the MIC of levofloxacin. MIC was determined as described above. Two dilutions containing 3.125 and 6.250 µl/ml, of T. syriacus essential oil were then added to the 96-well microtiter plates to determine the MIC. The lowest concentration of levofloxacin that completely inhibited visual growth in presence of essential oil was recorded as the MIC.

Results

On the basis of the primary screening results (table 2), O. syriacum and T. syriacus essential oils showed a good antibacterial activity against B. melitensis. Whereas, no antibacterial activity was demonstrated by the essential oils of R. officinalis L., S. palaestina Benth, M. piperia and L. stoechas L (data not shown). In addition, B. melitensis isolates were resistant to tetracycline (data not shown), but susceptible to doxycycline, ciprofloxacin, levofloxacin and ofloxacin.
Table 2

Inhibition zones (mm) of effective essential oils of some medicinal plants and antibiotics against B. melitensis

Isolate number Thymus syriacus Origanum syriacum Doxycycline Ciprofloxacine Levofloxacin Ofloxacin
1221827222922
2231661099
3251815262720
422176252112
520158271523
6221215272610
72317613208
822191614914
922187212722
10231818252619
11231222262626
1222137231916
1322181726229
1423166152015
15251612311620
1620199301812
Inhibition zones (mm) of effective essential oils of some medicinal plants and antibiotics against B. melitensis Also, O. syriacum, T. syriacus essential oils exhibited an inhibitory effect at a concentration of 50 mg/ml. Considering the diameter of the inhibition zone, O. syriacum and T. syriacus, which showed the highest anti-brucella activity, were chosen for further study. MIC50 values for O. syriacum and T. syriacus essential oils were 3.125 and 6.25 µl/ml, respectively. Whereas, MIC50 values for levofloxacin, ofloxacin, sparfloxacin, ciprofloxacin and doxycycline were 0.125, 0.5, 16, 64 and 0.5 µg/ml, respectively (table 3).
Table 3

MICs for Thymus Syriacus, Origanum syriacum and some antibiotics against B. melitensis

Essential oil or antibiotic Mean of MIC 50 Mean of MIC 90
Thymus syriacus 6.25 (µl/ml)NA
Origanum syriacum 3.125 (µl/ml)NA
Levofloxacin0.125 (µg/ml)32(µg/ml)
Ofloxacin0.5 (µg/ml)32(µg/ml)
Sparfloxacin16 (µg/ml)32(µg/ml)
Ciprofloxacin64 (µg/ml)NA
Doxycycline0.5 (µgl/ml)NA
MICs for Thymus Syriacus, Origanum syriacum and some antibiotics against B. melitensis In addition, table 4 revealed that T. syriacus essential oil reduced the MIC90 level of levofloxacin from 32 to 4 µg/ml in both isolates studied, whereas, it decreased the MIC50 level from 0.125 to 0.064 µg/ml in only one isolate.
Table 4

MICs of levofloxacin and Thymus syriacus essential oil combination

Isolate number MIC (µg/ml) without E.o
MIC (µg/ml) with 3.125 µl/ml of E.o
MIC (µg/ml) with 6.250 µl/ml of E.o
MIC 50 MIC 90 MIC 50 MIC 90 MIC 50 MIC 90
10.125320.06440.0642
20.125320.12540.1254

E.o=Essential oil

MICs of levofloxacin and Thymus syriacus essential oil combination E.o=Essential oil

Discussion

Human brucellosis therapy requires antibiotics which are capable of penetrating the macrophages and act efficiently under acidic conditions. Antimicrobial drug resistant strains emerge frequently,[33] and lead to treatment failure. Unfortunately, many strains of brucella, develop resistance to multiple conventional antibiotics. It is then necessary to discover new antimicrobial agents capable of acting against resistant strains, which could reduce relapsing cases or even cure the disease. In this context, medicinal plants which have fewer adverse effects and are less costly than antimicrobial agents, seem to be desired alternatives. Medicinal plants are found to be valuable for the treatment of infections caused by bacteria resistant to many antibiotics. Hassawi and Kharma,[34] reported that the extracts of many plants worldwide, were suitable for treating bacterial, fungal or viral infections. Brul and co-worker highlighted the mechanisms of antimicrobial effects in certain plants.[35] In addition, phenolic and aromatic compounds of medicinal plants seems to possess an essential antibacterial role.[36] The growth of B. melitensis is affected by thymol and carvacrol. These are major phenolic components of thymus oil with prominent outer membrane disintegration activity that increased the permeability to ATP through cytoplasmic membrane.[37],[38] In this context, several in vitro experiments showed a wide spectrum of antimicrobial activity in thymus oil and its phenolic components.[39] Most of the plants used in this study are used in traditional medicine across Syria to cure respiratory and gastrointestinal disorders. Thus, these plants could be explored to evaluate their efficacy against. As demonstrated in table 2, the efficacy of antimicrobial activities of essential oil of tested plants was determined, quantitively, by measuring the diameter of inhibition zones around the discs. Only O. syriacum and T. syriacus extracts inhibited the growth of B. melitensis. The MIC50 values of O. syriacum and T. syriacus aqueous extracts were 3.125 µl/ml and 6.25 µl/ml, respectively. Reuben et al.[40] found that the MIC and MBC often had comparable or close values, concluding that the essential oils of O. syriacum and T. syriacus possessed bactericidal effect on B. melitensis. Darabpour et al. found that the methanolic extract of Peganum harmala L seed exhibited a broad antibacterial activity against B. melitensis even at lowest concentration (50 mg/ml).[41] Shapouri and Rahnema reported the MIC of aqueous hops extract for B. abortus 544 and B. melitensis 16M, as 0.625 mg/ml, whereas that of acetonic and ethanolic extracts being 0.05 mg/ml.[42] Motamedi and his colleagues studied the effect of plant extract-antibiotic combination against B. melitensis, and observed a synergitistic activity in the combination of Oliveria decumbens extracts and doxycycline. In our in vitro study of T. syriacus aqueous extract of essential oil, a good additive activity against two B. melitensis isolates was demonstrated when it was used in combination with levofloxacin.

Conclusion

Our study showed that O. syriacum and T. syriacus essential oils were most effective against B. melitensis. This could provide a potential source of new antibacterial agents which is worthy of clinical trials. In addition, doxycycline, levofloxacin and ofloxacin were the most effective antibiotics. Moreover, levofloxacin and Thymus syriacus essential oil combination was more effective than either antibiotic or the essential oil alone. Further and more specific studies, in vivo, are recommended to determine the efficacy of these essential oils in the treatment of brucellosis infections.
  26 in total

Review 1.  Preservative agents in foods. Mode of action and microbial resistance mechanisms.

Authors:  S Brul; P Coote
Journal:  Int J Food Microbiol       Date:  1999-09-15       Impact factor: 5.277

Review 2.  Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics.

Authors:  R L MAGOFFIN; W W SPINK
Journal:  J Lab Clin Med       Date:  1951-06

4.  Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae.

Authors:  M Marino; C Bersani; G Comi
Journal:  Int J Food Microbiol       Date:  2001-08-05       Impact factor: 5.277

Review 5.  Recognition and optimum treatment of brucellosis.

Authors:  J Solera; E Martínez-Alfaro; A Espinosa
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

6.  Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis.

Authors:  Sylvia Valdezate; Ana Navarro; María J Medina-Pascual; Gema Carrasco; Juan A Saéz-Nieto
Journal:  J Antimicrob Chemother       Date:  2010-01       Impact factor: 5.790

Review 7.  Brucellosis in India - a review.

Authors:  Basappa G Mantur; Satish K Amarnath
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

8.  Inactivation of Escherichia coli O157:H7 by essential oil from Cinnamomum zeylanicum.

Authors:  Ouafae Senhaji; Mohamed Faid; Ichraq Kalalou
Journal:  Braz J Infect Dis       Date:  2007-04       Impact factor: 1.949

9.  Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Authors:  Javier Ariza; Mile Bosilkovski; Antonio Cascio; Juan D Colmenero; Michael J Corbel; Matthew E Falagas; Ziad A Memish; Mohammad Reza Hasanjani Roushan; Ethan Rubinstein; Nikolaos V Sipsas; Javier Solera; Edward J Young; Georgios Pappas
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

10.  Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].

Authors:  Oguz Karabay; Irfan Sencan; Derya Kayas; Idris Sahin
Journal:  BMC Infect Dis       Date:  2004-06-23       Impact factor: 3.090

View more
  8 in total

1.  Species-specific PCR for the Diagnosis and Determination of Antibiotic Susceptibilities of Brucella Strains Isolated from Tehran, Iran.

Authors:  Gholam Reza Irajian; Faramarz Masjedian Jazi; Reza Mirnejad; Vahhab Piranfar; Taghi Zahraei Salehi; Noor Amir Mozafari; Ehsanollah Ghaznavi-Rad; Mahmoud Khormali
Journal:  Iran J Pathol       Date:  2016

Review 2.  The current therapeutical strategies in human brucellosis.

Authors:  Mile Bosilkovski; Fariba Keramat; Jurica Arapović
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

Review 3.  Biological Activities of Three Essential Oils of the Lamiaceae Family.

Authors:  Gema Nieto
Journal:  Medicines (Basel)       Date:  2017-08-23

4.  Leveraging phytochemicals: the plant phylogeny predicts sources of novel antibacterial compounds.

Authors:  Malini A Prasad; Christine P Zolnik; Jeanmaire Molina
Journal:  Future Sci OA       Date:  2019-07-25

5.  Essential Oils of Seven Lamiaceae Plants and Their Antioxidant Capacity.

Authors:  David Aebisher; Jan Cichonski; Ewa Szpyrka; Sygit Masjonis; Grzegorz Chrzanowski
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

6.  Microarray-based long oligonucleotides probe designed for Brucella Spp. detection and identification of antibiotic susceptibility pattern.

Authors:  Zahra Khazaei; Ali Najafi; Vahhab Piranfar; Reza Mirnejad
Journal:  Electron Physician       Date:  2016-04-25

7.  Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice.

Authors:  Tsevelmaa N; Narangerel B; Odgerel O; Dariimaa D; Batkhuu J
Journal:  BMC Complement Altern Med       Date:  2018-05-03       Impact factor: 3.659

8.  The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes.

Authors:  Solee Jin; Mi-Young Lee
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.